FIELD: medicine; pharmacology.
SUBSTANCE: description is provided for the derivative of phenylalcan or phenyloxyalcan acids, formula (I), or their pharmaceutically acceptable salt or hydrolysable ester, where: R1 and R2 independently present the H or С1-3alkyl; X presents the O or (СН2)n where n is 0.1 or 2; R3 and R4 independently present the H, С1-3alkyl, -ОСН3, CF3, allyl or halogen; X1 presents О, S, SO2, SO or СН2; one of R5 and R6 independently presents hydrogen, and another - С1-6alkyl (including the ramified alkyl and, probably, the substituted С1-6alkoxy); R7 presents a phenyl or hexamerous heterocycle taken from pyridine, and each of specified phenyl or heterocycles is substituted by phenyl (probably, substituted by one ore more С1-3alkyl, CN, halogen or CF3). The pharmaceutical composition is also described.
EFFECT: compounds can be used in treatment of cardiovascular and endocrine diseases.
13 cl, 145 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED ISOXAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INFLAMMATION SUPPRESSION | 1996 |
|
RU2200158C2 |
| COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
| CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS | 2007 |
|
RU2485114C2 |
| DERIVATIVES OF PROPIONIC ACIDS AND THEIR USING AS hPPARs ACTIVATORS | 2003 |
|
RU2316539C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
| 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES | 2007 |
|
RU2463292C2 |
| DERIVATIVES OF 2,6-QUINOLINYL AND 2,6-NAPHTHYL, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, THEIR USING AS VLA-4 INHIBITORS AND INTERMEDIATE COMPOUNDS | 2003 |
|
RU2315041C2 |
| AZABICYCLO{3,1,0}HEXANE DERIVATIVES USED AS DOPAMINE RECEPTOR D3 MODULATORS | 2005 |
|
RU2434011C2 |
| N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER | 2005 |
|
RU2427572C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
